Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Pierre Fenaux

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kosmider Olivier; Gelsi-Boyer Véronique; Cheok Meyling; Grabar Sophie; Della-Valle Véronique; Picard Françoise; Viguié Franck; Quesnel Bruno; Beyne-Rauzy Odile; Solary Eric; Vey Norbert; Hunault-Berger Mathilde; Fenaux Pierre; Mansat-De Mas Véronique; Delabesse Eric; Guardiola Philippe; Lacombe Catherine; Vainchenker William; Preudhomme Claude; Dreyfus François; Bernard Olivier A; Birnbaum Daniel; Fontenay Michaëla;
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
Clozel Thomas; Renneville Aline; Venot Marion; Gardin Claude; Kelaidi Charikleia; Leroux Geneviève; Eclache Virginie; Preudhomme Claude; Fenaux Pierre; Adès Lionel
Slow relapse in acute myeloid leukemia with inv(16) or t(16;16).
Cassinat Bruno; de Botton Stéphane; Kelaidi Charikleia; Ades Lionel; Zassadowski Fabien; Guillemot Isabelle; Schlageter Marie-Helene; Raffoux Emmanuel; Harousseau Jean-Luc; Legrand Olivier; Escoffre-Barbe Martine; Reman Oumedaly; Gardembas Martine; Himberlin Chantal; Cahn Jean Yves; Guyotat Denis; Bouscary Didier; Parry Anne; Rousselot Philippe; Baruchel Andre; Dombret Hervé; Chevret Sylvie; Fenaux Pierre; Chomienne Christine
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Pierre Fenaux (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kosmider Olivier; Gelsi-Boyer Véronique; Cheok Meyling; Grabar Sophie; Della-Valle Véronique; Picard Françoise; Viguié Franck; Quesnel Bruno; Beyne-Rauzy Odile; Solary Eric; Vey Norbert; Hunault-Berger Mathilde; Fenaux Pierre; Mansat-De Mas Véronique; Delabesse Eric; Guardiola Philippe; Lacombe Catherine; Vainchenker William; Preudhomme Claude; Dreyfus François; Bernard Olivier A; Birnbaum Daniel; Fontenay Michaëla;
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
Blood 2009;114(15):3285-91.
2009: Clozel Thomas; Renneville Aline; Venot Marion; Gardin Claude; Kelaidi Charikleia; Leroux Geneviève; Eclache Virginie; Preudhomme Claude; Fenaux Pierre; Adès Lionel
Slow relapse in acute myeloid leukemia with inv(16) or t(16;16).
Haematologica 2009;94(10):1466-8.
2009: Cassinat Bruno; de Botton Stéphane; Kelaidi Charikleia; Ades Lionel; Zassadowski Fabien; Guillemot Isabelle; Schlageter Marie-Helene; Raffoux Emmanuel; Harousseau Jean-Luc; Legrand Olivier; Escoffre-Barbe Martine; Reman Oumedaly; Gardembas Martine; Himberlin Chantal; Cahn Jean Yves; Guyotat Denis; Bouscary Didier; Parry Anne; Rousselot Philippe; Baruchel Andre; Dombret Hervé; Chevret Sylvie; Fenaux Pierre; Chomienne Christine
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
Leukemia research 2009;33(9):1178-82.
2009: Kelaidi Charikleia; Chevret Sylvie; De Botton Stéphane; Raffoux Emmanuel; Guerci Agnès; Thomas Xavier; Pigneux Arnaud; Lamy Thierry; Rigal-Huguet Françoise; Meyer-Monard Sandrine; Chevallier Patrice; Maloisel Frédéric; Deconinck Erick; Ferrant Augustin; Fegueux Nathalie; Ifrah Norbert; Sanz Miguel; Dombret Hervé; Fenaux Pierre; Adès Lionel
Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2668-76.
2009: Boehrer S; Adès L; Tajeddine N; Hofmann W K; Kriener S; Bug G; Ottmann O G; Ruthardt M; Galluzzi L; Fouassier C; Tailler M; Olaussen K A; Gardin C; Eclache V; de Botton S; Thepot S; Fenaux P; Kroemer G
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.
Oncogene 2009;28(22):2205-18.
2009: Adès Lionel; Boehrer Simone; Prebet Thomas; Beyne-Rauzy Odile; Legros Laurence; Ravoet Christophe; Dreyfus François; Stamatoullas Aspasia; Chaury Marie Pierre; Delaunay Jacques; Laurent Guy; Vey Norbert; Burcheri Sara; Mbida Rose-Marie; Hoarau Natacha; Gardin Claude; Fenaux Pierre
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
Blood 2009;113(17):3947-52.
2009: Tamburini J; Elie C; Park S; Beyne-Rauzy O; Gardembas M; Berthou C; Mahe B; Sanhes L; Stamatoullas A; Vey N; Aouba A; Slama B; Quesnel B; Vekhoff A; Sotto J J; Vassilief D; Al-Nawakil C; Fenaux P; Dreyfus F; Bouscary D;
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
Leukemia research 2009;33(4):547-50.
2009: Itzykson Raphael; Fenaux Pierre
Optimal sequencing of treatments for patients with myelodysplastic syndromes.
Current opinion in hematology 2009;16(2):77-83.
2009: Fenaux Pierre; Mufti Ghulam J; Hellstrom-Lindberg Eva; Santini Valeria; Finelli Carlo; Giagounidis Aristoteles; Schoch Robert; Gattermann Norbert; Sanz Guillermo; List Alan; Gore Steven D; Seymour John F; Bennett John M; Byrd John; Backstrom Jay; Zimmerman Linda; McKenzie David; Beach Cl; Silverman Lewis R;
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
The lancet oncology 2009;10(3):223-32.
2009: Grosjean-Raillard J; Tailler M; Adès L; Perfettini J-L; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene 2009;28(8):1099-109.
2009: Sanz Miguel A; Grimwade David; Tallman Martin S; Lowenberg Bob; Fenaux Pierre; Estey Elihu H; Naoe Tomoki; Lengfelder Eva; Büchner Thomas; Döhner Hartmut; Burnett Alan K; Lo-Coco Francesco
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Blood 2009;113(9):1875-91.
2009: Szende Agota; Schaefer Caroline; Goss Thomas F; Heptinstall Kathy; Knight Robert; Lübbert Michael; Deschler Barbara; Fenaux Pierre; Mufti Ghulam J; Killick Sally; List Alan F
Valuation of transfusion-free living in MDS: results of health utility interviews with patients.
Health and quality of life outcomes 2009;7():81.
2008: Boehrer Simone; Adès Lionel; Galluzzi Lorenzo; Tajeddine Nicolas; Tailler Maximilien; Gardin Claude; de Botton Stéphane; Fenaux Pierre; Kroemer Guido
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison.
Biochemical pharmacology 2008;76(11):1417-25.
2008: Gmidène Abir; Sennana Hlima; Fenaux Pierre; Laatiri Adnène; Zarrouk Mohamed; Bouaziz Houssem; Harrabi Imed; Saad Ali
Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
Leukemia research 2008;32(12):1824-9.
2008: Mufti Ghulam J; Bennett John M; Goasguen Jean; Bain Barbara J; Baumann Irith; Brunning Richard; Cazzola Mario; Fenaux Pierre; Germing Ulrich; Hellström-Lindberg Eva; Jinnai Itsuro; Manabe Atsushi; Matsuda Akira; Niemeyer Charlotte M; Sanz Guillermo; Tomonaga Masao; Vallespi Teresa; Yoshimi Ayami;
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Haematologica 2008;93(11):1712-7.
2008: Kiladjian Jean-Jacques; Cassinat Bruno; Chevret Sylvie; Turlure Pascal; Cambier Nathalie; Roussel Murielle; Bellucci Sylvia; Grandchamp Bernard; Chomienne Christine; Fenaux Pierre
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera.
Blood 2008;112(8):3065-72.
2008: Grosjean-Raillard Jennifer; Adès Lionel; Boehrer Simone; Tailler Maximilien; Fabre Claire; Braun Thorsten; De Botton Stéphane; Israel Alain; Fenaux Pierre; Kroemer Guido
Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Apoptosis : an international journal on programmed cell death 2008;13(9):1148-61.
2008: Kantarjian Hagop; O'Brien Susan; Ravandi Farhad; Cortes Jorge; Shan Jianqin; Bennett John M; List Alan; Fenaux Pierre; Sanz Guillermo; Issa Jean-Pierre; Freireich Emil J; Garcia-Manero Guillermo
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.
Cancer 2008;113(6):1351-61.
2008: Zassadowski Fabien; Ades Lionel; Schlageter Marie-Helene; Chevret Sylvie; Guillemot Isabelle; Fenaux Pierre; Chomienne Christine; Cassinat Bruno
Auer rods and differentiation in acute promyelocytic leukemia.
British journal of haematology 2008;142(6):998-1000.
2008: Kouroupi Eirini; Zoi Katerina; Parquet Nathalie; Zoi Christine; Kiladjian Jean-Jacques; Grigoraki Vassiliki; Vainchenker William; Lellouche Franck; Marzac Christophe; Schlageter Marie-Hélène; Dosquet Christine; Scott Linda M; Fenaux Pierre; Loukopoulos Dimitris; Chomienne Christine; Cassinat Bruno
Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.
British journal of haematology 2008;142(4):676-9.
2008: Godeau Bertrand; Porcher Raphael; Fain Olivier; Lefrère François; Fenaux Pierre; Cheze Stéphane; Vekhoff Anne; Chauveheid Marie-Paule; Stirnemann Jerôme; Galicier Lionel; Bourgeois Emmanuelle; Haiat Stéphanie; Varet Bruno; Leporrier Michel; Papo Thomas; Khellaf Mehdi; Michel Marc; Bierling Philippe
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
Blood 2008;112(4):999-1004.
2008: Fabre Claire; Grosjean Jennifer; Tailler Maximilien; Boehrer Simone; Adès Lionel; Perfettini Jean-Luc; de Botton Stéphane; Fenaux Pierre; Kroemer Guido
A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts.
Cell cycle (Georgetown, Tex.) 2008;7(14):2139-45.
2008: Braun Thorsten; Fenaux Pierre
Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 2008;141(5):576-86.
2008: Giagounidis Aristoteles; Fenaux Pierre; Mufti Ghulam J; Muus Petra; Platzbecker Uwe; Sanz Guillermo; Cripe Larry; Von Lilienfeld-Toal Marie; Wells Richard A
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.
Annals of hematology 2008;87(5):345-52.
2008: Kiladjian Jean-Jacques; Cervantes Francisco; Leebeek Franck W G; Marzac Christophe; Cassinat Bruno; Chevret Sylvie; Cazals-Hatem Dominique; Plessier Aurélie; Garcia-Pagan Juan-Carlos; Darwish Murad Sarwa; Raffa Sebastian; Janssen Harry L A; Gardin Claude; Cereja Sophie; Tonetti Carole; Giraudier Stéphane; Condat Bertrand; Casadevall Nicole; Fenaux Pierre; Valla Dominique C
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.
Blood 2008;111(10):4922-9.
2008: Bowen David T; Fenaux Pierre; Hellstrom-Lindberg Eva; de Witte Theo
Time-dependent prognostic scoring system for myelodysplastic syndromes has significant limitations that may influence its reproducibility and practical application.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1180; author reply 1181-2.
2008: Kiladjian Jean-Jacques; Visentin Géraldine; Viey Emilie; Chevret Sylvie; Eclache Virginie; Stirnemann Jerome; Bourhis Jean Henri; Chouaib Salem; Fenaux Pierre; Caignard Anne
Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
Haematologica 2008;93(3):381-9.
2008: Eclache Virginie; Da Rocha Anna; Le Roux Génevieve; Fenaux Pierre
Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide.
Haematologica 2008;93(2):315-6.
2008: Kelaidi Charikleia; Eclache Virginie; Fenaux Pierre
The role of lenalidomide in the management of myelodysplasia with del 5q.
British journal of haematology 2008;140(3):267-78.
2008: Adès Lionel; Sanz Miguel A; Chevret Sylvie; Montesinos Pau; Chevallier Patrice; Raffoux Emmanuel; Vellenga Edo; Guerci Agnès; Pigneux Arnaud; Huguet Francoise; Rayon Consuelo; Stoppa Anne Marie; de la Serna Javier; Cahn Jean-Yves; Meyer-Monard Sandrine; Pabst Thomas; Thomas Xavier; de Botton Stéphane; Parody Ricardo; Bergua Juan; Lamy Thierry; Vekhoff Anne; Negri Silvia; Ifrah Norbert; Dombret Hervé; Ferrant Augustin; Bron Dominique; Degos Laurent; Fenaux Pierre
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
Blood 2008;111(3):1078-84.
2008: Boehrer Simone; Adès Lionel; Braun Thorsten; Galluzzi Lorenzo; Grosjean Jennifer; Fabre Claire; Le Roux Génèviève; Gardin Claude; Martin Antoine; de Botton Stéphane; Fenaux Pierre; Kroemer Guido
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study.
Blood 2008;111(4):2170-80.
2008: Cassinat B; Laguillier C; Gardin C; de Beco V; Burcheri S; Fenaux P; Chomienne C; Kiladjian J-J;
Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(2):452-3.
2008: Capovilla Mathieu; Cayuela Jean-Michel; Bilhou-Nabera Chrystèle; Gardin Claude; Letestu Remi; Baran-Marzak Fanny; Fenaux Pierre; Martin Antoine
Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy.
European journal of haematology 2008;80(1):81-6.
2008: Park Sophie; Grabar Sophie; Kelaidi Charikleia; Beyne-Rauzy Odile; Picard Françoise; Bardet Valérie; Coiteux Valérie; Leroux Geneviève; Lepelley Pascale; Daniel Marie-Thérèse; Cheze Stéphane; Mahé Béatrice; Ferrant Augustin; Ravoet Christophe; Escoffre-Barbe Martine; Adès Lionel; Vey Norbert; Aljassem Lina; Stamatoullas Aspasia; Mannone Lionel; Dombret Hervé; Bourgeois Keith; Greenberg Peter; Fenaux Pierre; Dreyfus François;
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.
Blood 2008;111(2):574-82.
2007: Orsi Laurent; Troussard Xavier; Monnereau Alain; Berthou Christian; Fenaux Pierre; Marit Gerald; Soubeyran Pierre; Huguet Françoise; Milpied Noel; Leporrier Michel; Hemon Denis; Clavel Jacqueline
Occupation and lymphoid malignancies: results from a French case-control study.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2007;49(12):1339-50.
2007: Omidvar Nader; Kogan Scott; Beurlet Stephanie; le Pogam Carole; Janin Anne; West Robert; Noguera Maria-Elena; Reboul Murielle; Soulie Annie; Leboeuf Christophe; Setterblad Niclas; Felsher Dean; Lagasse Eric; Mohamedali Azim; Thomas N Shaun B; Fenaux Pierre; Fontenay Michaela; Pla Marika; Mufti Ghulam J; Weissman Irving; Chomienne Christine; Padua Rose Ann
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
Cancer research 2007;67(24):11657-67.
2007: Delva Laurent; Zelent Arthur; Naoe Tomoki; Fenaux Pierre; Waxman Samuel; Degos Laurent; Chomienne Christine
Meeting report: the 11th International Conference on Differentiation Therapy and Innovative Therapeutics in Oncology.
Cancer research 2007;67(22):10635-7.
2007: Kiladjian J-J; Fenaux P; Caignard A
Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(11):2237-9.
2007: Tavernier E; Boiron J-M; Huguet F; Bradstock K; Vey N; Kovacsovics T; Delannoy A; Fegueux N; Fenaux P; Stamatoullas A; Tournilhac O; Buzyn A; Reman O; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant J-P; Dombret H; Thomas X;
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):1907-14.
2007: Monnereau A; Orsi L; Troussard X; Berthou C; Fenaux P; Marit G; Soubeyran P; Huguet F; Milpied N; Leporrier M; Hemon D; Clavel J
History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):2075-9.
2007: Harousseau Jean-Luc; Lancet Jeffrey E; Reiffers Josy; Lowenberg Bob; Thomas Xavier; Huguet Francoise; Fenaux Pierre; Zhang Steven; Rackoff Wayne; De Porre Peter; Stone Richard;
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.
Blood 2007;109(12):5151-6.
2007: Gardin Claude; Turlure Pascal; Fagot Thierry; Thomas Xavier; Terre Christine; Contentin Nathalie; Raffoux Emmanuel; de Botton Stephane; Pautas Cecile; Reman Oumedaly; Bourhis Jean-Henri; Fenaux Pierre; Castaigne Sylvie; Michallet Mauricette; Preudhomme Claude; de Revel Thierry; Bordessoule Dominique; Dombret Herve
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.
Blood 2007;109(12):5129-35.
2007: Braun Thorsten; Carvalho Gabrielle; Grosjean Jennifer; Ades Lionel; Fabre Claire; Boehrer Simone; Debili Najet; Fenaux Pierre; Kroemer Guido
Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation.
Apoptosis : an international journal on programmed cell death 2007;12(6):1101-8.
2007: Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene 2007;26(28):4071-83.
2007: Fenaux Pierre; Raza Azra; Mufti Ghulam J; Aul Carlo; Germing Ulrich; Kantarjian Hagop; Cripe Larry; Kerstens René; De Porre Peter; Kurzrock Razelle
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.
Blood 2007;109(10):4158-63.
2007: Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Oncogene 2007;26(16):2299-307.
2007: Thomas X; Raffoux E; Botton S de; Pautas C; Arnaud P; de Revel T; Reman O; Terré C; Corront B; Gardin C; Le Q-H; Quesnel B; Cordonnier C; Bourhis J-H; Elhamri M; Fenaux P; Preudhomme C; Michallet M; Castaigne S; Dombret H
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):453-61.
2007: Kiladjian J J; Casadevall N; Vainchenker W; Fenaux P
The first international meeting on V617F JAK2 mutation and its relevance in Philadelphia-negative myeloproliferative disorders.
Pathologie-biologie 2007;55(2):85-7.
2007: Coiteux Valérie; Onclercq-Delic Rosine; Fenaux Pierre; Amor-Guéret Mounira
Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Leukemia research 2007;31(3):353-8.
2007: Le Deley Marie-Cécile; Suzan Florence; Cutuli Bruno; Delaloge Suzette; Shamsaldin Akthar; Linassier Claude; Clisant Stéphanie; de Vathaire Florent; Fenaux Pierre; Hill Catherine
Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):292-300.
2007: Fenaux P; Wang Z Z; Degos L
Treatment of acute promyelocytic leukemia by retinoids.
Current topics in microbiology and immunology 2007;313():101-28.
2006: Cassinat Bruno; Guillemot Isabelle; Moluçon-Chabrot Cécile; Zassadowski Fabien; Fenaux Pierre; Tournilhac Olivier; Chomienne Christine
Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Haematologica 2006;91(12 Suppl):ECR58.
2006: Adès Lionel; Chevret Sylvie; Raffoux Emmanuel; de Botton Stephane; Guerci Agnes; Pigneux Arnaud; Stoppa Anne Marie; Lamy Thierry; Rigal-Huguet Francoise; Vekhoff Anne; Meyer-Monard Sandrine; Maloisel Frederic; Deconinck Eric; Ferrant Augustin; Thomas Xavier; Fegueux Nathalie; Chomienne Christine; Dombret Herve; Degos Laurent; Fenaux Pierre;
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5703-10.
2006: Adès Lionel; Fenaux Pierre
Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
Clinical advances in hematology & oncology : H&O 2006;4(9):678-82.
2006: Robin Marie; Andreu-Gallien Juliette; Schlageter Marie-Helene; Bengoufa Djaouida; Guillemot Isabelle; Pokorna Katerina; Robert Carine; Larghero Jerome; Rousselot Philippe; Raffoux Emmanuel; Dombret Herve; Fenaux Pierre; Pla Marika; Charron Dominique; Padua Rose-Ann; Chomienne Christine
Frequent antibody production against RARalpha in both APL mice and patients.
Blood 2006;108(6):1972-4.
2006: Kiladjian Jean-Jacques; Cassinat Bruno; Turlure Pascal; Cambier Nathalie; Roussel Murielle; Bellucci Sylvia; Menot Marie-Laurence; Massonnet Gerald; Dutel Jean-Luc; Ghomari Kamel; Rousselot Philippe; Grange Marie-Jose; Chait Yasmina; Vainchenker William; Parquet Nathalie; Abdelkader-Aljassem Lina; Bernard Jean-François; Rain Jean-Didier; Chevret Sylvie; Chomienne Christine; Fenaux Pierre
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a.
Blood 2006;108(6):2037-40.
2006: Thomas Xavier; Pigneux Arnaud; Raffoux Emmanuel; Huguet Francoise; Caillot Denis; Fenaux Pierre
Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed acute promyelocytic leukemia.
Haematologica 2006;91(7):996-7.
2006: Ingram W; Lea N C; Cervera J; Germing U; Fenaux P; Cassinat B; Kiladjian J J; Varkonyi J; Antunovic P; Westwood N B; Arno M J; Mohamedali A; Gaken J; Kontou T; Czepulkowski B H; Twine N A; Tamaska J; Csomer J; Benedek S; Gattermann N; Zipperer E; Giagounidis A; Garcia-Casado Z; Sanz G; Mufti G J
The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(7):1319-21.
2006: Kiladjian Jean-Jacques; Rain Jean-Didier; Bernard Jean-Francois; Briere Jean; Chomienne Christine; Fenaux Pierre
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Seminars in thrombosis and hemostasis 2006;32(4 Pt 2):417-21.
2006: Mannone L; Gardin C; Quarre M C; Bernard J F; Vassilieff D; Ades L; Park S; Vaultier S; Hamza F; Beyne-rauzy M O; Cheze S; Giraudier S; Agape P; Legros L; Voillat L; Dreyfus F; Fenaux P;
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study.
British journal of haematology 2006;133(5):513-9.
2006: Vey Norbert; Bosly Andre; Guerci Agnes; Feremans Walter; Dombret Herve; Dreyfus Francois; Bowen David; Burnett Alan; Dennis Mike; Ribrag Vincent; Casadevall Nicole; Legros Laurence; Fenaux Pierre
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2465-71.
2006: Kiladjian J-J; Elkassar N; Cassinat B; Hetet G; Giraudier S; Balitrand N; Conejero C; Briere J; Fenaux P; Chomienne C; Grandchamp B
Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(6):1181-3.
2006: Kelaidi C; Ades L; Chevret S; Sanz M; Guerci A; Thomas X; de Botton S; Raffoux E; Rayon C; Fegueux N; Bordessoule D; Rigal-Huguet F; Link H; Stoppa A; Vekhoff A; Meyer-Monard S; Castaigne S; Dombret H; Degos L; Fenaux P
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):905-7.
2006: Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
Targeting NF-kappaB in hematologic malignancies.
Cell death and differentiation 2006;13(5):748-58.
2006: Ducastelle Sophie; Adès Lionel; Gardin Claude; Dombret Hervé; Prébet Thomas; Deconinck Eric; Rio Bernard; Thomas Xavier; Debotton Stephan; Guerci Agnès; Gratecos Nicole; Stamatoullas Aspasia; Fegueux Nathalie; Dreyfus François; Fenaux Pierre; Wattel Eric
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Haematologica 2006;91(3):373-6.
2006: Roumier C; Lejeune-Dumoulin S; Renneville A; Goethgeluck A S; Philippe N; Fenaux P; Preudhomme C
Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):433-6.
2006: Kiladjian J-J; Bourgeois E; Lobe I; Braun T; Visentin G; Bourhis J-H; Fenaux P; Chouaib S; Caignard A
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):463-70.
2006: Campbell Peter J; Griesshammer Martin; Döhner Konstanze; Döhner Hartmut; Kusec Rajko; Hasselbalch Hans C; Larsen Thomas Stauffer; Pallisgaard Niels; Giraudier Stéphane; Le Bousse-Kerdilès Marie-Caroline; Desterke Christophe; Guerton Bernadette; Dupriez Brigitte; Bordessoule Dominique; Fenaux Pierre; Kiladjian Jean-Jacques; Viallard Jean-François; Brière Jean; Harrison Claire N; Green Anthony R; Reilly John T
V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.
Blood 2006;107(5):2098-100.
2006: Braun Thorsten; Carvalho Gabrielle; Coquelle Arnaud; Vozenin Marie-Catherine; Lepelley Pascale; Hirsch François; Kiladjian Jean-Jacques; Ribrag Vincent; Fenaux Pierre; Kroemer Guido
NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome.
Blood 2006;107(3):1156-65.
2006: de Botton S; Sanz M A; Chevret S; Dombret H; Martin G; Thomas X; Mediavilla J D; Recher C; Ades L; Quesnel B; Brault P; Fey M; Wandt H; Machover D; Guerci A; Maloisel F; Stoppa A M; Rayon C; Ribera J M; Chomienne C; Degos L; Fenaux P;
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):35-41.
2006: Fenaux Pierre; Kelaidi Charikleia
Treatment of the 5q- syndrome.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():192-8.
2005: Bouscary Didier; Legros Laurence; Tulliez Micheline; Dubois Stéphanie; Mahe Béatrice; Beyne-Rauzy Odile; Quarre Marie C; Vassilief Dominique; Varet Bruno; Aouba Achille; Gardembas Martine; Giraudier Stéphane; Guerci Agnès; Rousselot Philippe; Gaillard Fanny; Moreau Anne; Rousselet Marie C; Ifrah Norbert; Fenaux Pierre; Dreyfus François;
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies.
British journal of haematology 2005;131(5):609-18.
2005: Fenaux Pierre
Inhibitors of DNA methylation: beyond myelodysplastic syndromes.
Nature clinical practice. Oncology 2005;2 Suppl 1():S36-44.
2005: Gardin Claude; Fenaux Pierre
[Dysmyelopoeisis]
La Revue du praticien 2005;55(17):1957-61.
2005: Boissel Nicolas; Renneville Aline; Biggio Valeria; Philippe Nathalie; Thomas Xavier; Cayuela Jean-Michel; Terre Christine; Tigaud Isabelle; Castaigne Sylvie; Raffoux Emmanuel; De Botton Stephane; Fenaux Pierre; Dombret Herve; Preudhomme Claude
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.
Blood 2005;106(10):3618-20.
2005: Sanz Miguel A; Fenaux Pierre; Lo Coco Francesco;
Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence.
Haematologica 2005;90(9):1231-5.
2005: Fenaux Pierre
Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS).
Seminars in oncology 2005;32(4 Suppl 5):S11-5.
2005: Thomas X; Le Qh; Botton S de; Raffoux E; Chelghoum Y; Pautas C; Dreyfus F; Dhedin N; Vekhoff A; Troncy J; Pigneux A; Revel T de; Reman O; Travade P; Thiebaut A; Guerci A; Elhamri M; Fenaux P; Dombret H; Michallet M
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
Leukemia & lymphoma 2005;46(7):1007-16.
2005: Callens C; Chevret S; Cayuela J-M; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa A-M; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1153-60.
2005: Cornillon Jérôme; Fawaz Abir; Depil Stéphane; Dufosse Françoise; Duhamel Alain; Bauters Francis; Fenaux Pierre; Jouet Jean-Pierre; Yakoub-Agha Ibrahim
Outcome of patients less than 55 years of age with high-risk acute leukemia who did not have an human leukocyte antigen-identical related donor: a long-term study of 97 consecutive patients.
Leukemia & lymphoma 2005;46(6):841-9.
2005: Hugues Leroy; Cavé Hélène; Philippe Nathalie; Pereira Sabrina; Fenaux Pierre; Preudhomme Claude
Mutations of PTPN11 are rare in adult myeloid malignancies.
Haematologica 2005;90(6):853-4.
2005: Kiladjian Jean-Jacques; Bernard Jean-Francois; Fenaux Pierre
Is life expectancy of polycythemia vera patients clearly different from that of the general population?
The American journal of medicine 2005;118(5):565; author reply 565-6.
2005: Eclache Virginie; Viguie Franck; Frocrain Claudie; Cassinat Bruno; Chomienne Christine; Cymbalista Florence; Fenaux Pierre
A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
Cancer genetics and cytogenetics 2005;159(1):69-73.
2005: Roche-Lestienne C; Lepers S; Soenen-Cornu V; Kahn J-E; Laï J-L; Hachulla E; Drupt F; Demarty A-L; Roumier A-S; Gardembas M; Dib M; Philippe N; Cambier N; Barete S; Libersa C; Bletry O; Hatron P-Y; Quesnel B; Rose C; Maloum K; Blanchet O; Fenaux P; Prin L; Preudhomme C
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):792-8.
2005: Mistry Anita R; Felix Carolyn A; Whitmarsh Ryan J; Mason Annabel; Reiter Andreas; Cassinat Bruno; Parry Anne; Walz Christoph; Wiemels Joseph L; Segal Mark R; Adès Lionel; Blair Ian A; Osheroff Neil; Peniket Andrew J; Lafage-Pochitaloff Marina; Cross Nicholas C P; Chomienne Christine; Solomon Ellen; Fenaux Pierre; Grimwade David
DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
The New England journal of medicine 2005;352(15):1529-38.
2005: Soenen-Cornu Valérie; Tourino Cristina; Bonnet Marie-Laure; Guillier Martine; Flamant Stéphane; Kotb Rami; Bernheim Alain; Bourhis Jean-Henri; Preudhomme Claude; Fenaux Pierre; Turhan Ali G
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.
Oncogene 2005;24(15):2441-8.
2005: de Labarthe A; Pautas C; Thomas X; de Botton S; Bordessoule D; Tilly H; de Revel T; Bastard C; Preudhomme C; Michallet M; Fenaux P; Bastie J-N; Socié G; Cordonnier C; Dombret H;
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
Bone marrow transplantation 2005;35(8):767-73.
2005: Barouk-Simonet Emmanuelle; Soenen-Cornu Valérie; Roumier Christophe; Cosson Alain; Laï Jean-Luc; Fenaux Pierre; Preudhomme Claude
Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.
Cancer genetics and cytogenetics 2005;157(2):118-26.
2005: Leroy H; de Botton S; Grardel-Duflos N; Darre S; Leleu X; Roumier C; Morschhauser F; Lai J-L; Bauters F; Fenaux P; Preudhomme C
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(3):367-72.
2005: Leroy H; Roumier C; Huyghe P; Biggio V; Fenaux P; Preudhomme C
CEBPA point mutations in hematological malignancies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(3):329-34.
2005: Ades L; Chevret S; De Botton S; Thomas X; Dombret H; Beve B; Sanz M; Guerci A; Miguel J S; Dela Serna J; Garo C; Stoppa A M; Reman O; Stamatoulas A; Fey M; Cahn J Y; Sotto J J; Bourhis J H; Parry A; Chomienne C; Degos L; Fenaux P;
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(2):230-3.
2005: de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa A M; Reman O; Stamatoulas A; Fey M; Cahn J Y; Sotto J J; Bourhis J H; Parry A; Chomienne C; Degos L; Fenaux P
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):120-6.
2004: Gardin Claude; Fenaux Pierre
Supportive care including growth factors in myelodysplastic syndromes.
Reviews in clinical and experimental hematology 2004;8(2):E3.
2004: Thomas Xavier; Boiron Jean-Michel; Huguet Françoise; Dombret Hervé; Bradstock Ken; Vey Norbert; Kovacsovics Tibor; Delannoy André; Fegueux Nathalie; Fenaux Pierre; Stamatoullas Aspasia; Vernant Jean-Paul; Tournilhac Olivier; Buzyn Agnès; Reman Oumedaly; Charrin Christiane; Boucheix Claude; Gabert Jean; Lhéritier Véronique; Fiere Denis
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4075-86.
2004: Castaigne Sylvie; Chevret Sylvie; Archimbaud Eric; Fenaux Pierre; Bordessoule Dominique; Tilly Hervé; de Revel Thierry; Simon Marc; Dupriez Brigitte; Renoux Michel; Janvier Maud; Micléa Jean-Michel; Thomas Xavier; Bastard Christian; Preudhomme Claude; Bauters Francis; Degos Laurent; Dombret Hervé
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Blood 2004;104(8):2467-74.
2004: Casadevall Nicole; Durieux Pierre; Dubois Stéphanie; Hemery François; Lepage Eric; Quarré Marie-Catherine; Damaj Gandhi; Giraudier Stéphane; Guerci Agnès; Laurent Guy; Dombret Hervé; Chomienne Christine; Ribrag Vincent; Stamatoullas Aspasia; Marie Jean-Pierre; Vekhoff Anne; Maloisel Frédéric; Navarro Robert; Dreyfus François; Fenaux Pierre
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial.
Blood 2004;104(2):321-7.
2004: Fenaux Pierre
Myelodysplastic syndromes: From pathogenesis and prognosis to treatment.
Seminars in hematology 2004;41(2 Suppl 4):6-12.
2004: de Botton S; Coiteux V; Chevret S; Rayon C; Vilmer E; Sanz M; de La Serna J; Philippe N; Baruchel A; Leverger G; Robert A; San Miguel J; Conde E; Sotto J J; Bordessoule D; Fegueux N; Fey M; Parry A; Chomienne C; Degos L; Fenaux P
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1404-12.
2004: Prébet Thomas; Ducastelle Sophie; Debotton Stephan; Stamatoullas Aspasia; Deconinck Eric; Fruchart Christophe; Gratecos Nicole; Ifrah Norbert; Dreyfus François; Fenaux Pierre; Wattel Eric;
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(3):209-15.
2004: Huyghe Pauline; Dassonneville Laurent; Fenaux Pierre; Bailly Christian
Hydroxyurea-induced apoptosis in an EBV-immortalized lymphoblastoid cell line.
Oncology research 2004;14(4-5):235-45.
2003: Fenaux Pierre; Chevret Sylvie; de Botton Stéphane
Treatment of older adults with acute promyelocytic leukaemia.
Best practice & research. Clinical haematology 2003;16(3):495-501.
2003: Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(8):1600-4.
2003: Delaunay Jacques; Vey Norbert; Leblanc Thierry; Fenaux Pierre; Rigal-Huguet Françoise; Witz Francis; Lamy Thierry; Auvrignon Anne; Blaise Didier; Pigneux Arnaud; Mugneret Francine; Bastard Christian; Dastugue Nicole; Van den Akker Jacqueline; Fière Denis; Reiffers Josy; Castaigne Sylvie; Leverger Guy; Harousseau Jean-Luc; Dombret Herve;
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Blood 2003;102(2):462-9.
2003: Beaumont M; Sanz M; Carli P M; Maloisel F; Thomas X; Detourmignies L; Guerci A; Gratecos N; Rayon C; San Miguel J; Odriozola J; Cahn J Y; Huguet F; Vekhof A; Stamatoulas A; Dombret H; Capote F; Esteve J; Stoppa A M; Fenaux P
Therapy-related acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2123-37.
2003: Ribrag V; Koscielny S; Carpiuc I; Cebotaru C; Vande Walle H; Talbot M; Fenaux P; Bosq J
Prognostic value of GST-pi expression in diffuse large B-cell lymphomas.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(5):972-7.
2003: Bourgeois Emmanuelle; Caulier Marie T; Delarozee Catherine; Brouillard Marc; Bauters Francis; Fenaux Pierre
Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis.
British journal of haematology 2003;120(6):1079-88.
2003: de Botton S; Chevret S; Coiteux V; Dombret H; Sanz M; San Miguel J; Caillot D; Vekhoff A; Gardembas M; Stamatoulas A; Conde E; Guerci A; Gardin C; Fey M; Cony Makhoul D; Reman O; de la Serna J; Lefrere F; Chomienne C; Degos L; Fenaux P;
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):339-42.
2003: Ribrag V; Suzan F; Ravoet C; Feremans W; Guerci A; Dreyfus F; Damaj G; Vantelon J M; Bourhis J H; Fenaux P
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):319-22.
2003: Vereecque R; Saudemont A; Wickham T J; Gonzalez R; Hetuin D; Fenaux P; Quesnel B
Gamma-irradiation enhances transgene expression in leukemic cells.
Gene therapy 2003;10(3):227-33.
2003: Roumier Christophe; Eclache Virginie; Imbert Michelle; Davi Frederic; MacIntyre Elizabeth; Garand Richard; Talmant Pascaline; Lepelley Pascale; Lai Jean Luc; Casasnovas Olivier; Maynadie Marc; Mugneret Francine; Bilhou-Naberra Chrystele; Valensi Francoise; Radford Isabelle; Mozziconacci Marie Joelle; Arnoulet Christine; Duchayne Eliane; Dastugue Nicole; Cornillet Pascale; Daliphard Sylvie; Garnache Francine; Boudjerra Najiba; Jouault Helene; Fenneteau Odile; Pedron Béatrice; Berger Roland; Flandrin Georges; Fenaux Pierre; Preudhomme Claude;
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).
Blood 2003;101(4):1277-83.
2003: Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
New mechanisms of AML1 gene alteration in hematological malignancies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(1):9-16.
2002: Fenaux Pierre
[ Myelodysplastic syndrome]
La Revue du praticien 2002;52(20):2301-8.
2002: Lamandin Charlotte; Sagot Christophe; Roumier Christophe; Lepelley Pascale; De Botton Stéphane; Cosson Alain; Fenaux Pierre; Preudhomme Claude
Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?
Blood 2002;100(13):4680-1.
2002: Preudhomme Claude; Sagot Christophe; Boissel Nicolas; Cayuela Jean-Michel; Tigaud Isabelle; de Botton Stéphane; Thomas Xavier; Raffoux Emmanuel; Lamandin Charlotte; Castaigne Sylvie; Fenaux Pierre; Dombret Hervé;
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).
Blood 2002;100(8):2717-23.
2002: Dombret Hervé; Gabert Jean; Boiron Jean-Michel; Rigal-Huguet Françoise; Blaise Didier; Thomas Xavier; Delannoy André; Buzyn Agnès; Bilhou-Nabera Chrystèle; Cayuela Jean-Michel; Fenaux Pierre; Bourhis Jean-Henri; Fegueux Nathalie; Charrin Christiane; Boucheix Claude; Lhéritier Véronique; Espérou Hélène; MacIntyre Elizabeth; Vernant Jean-Paul; Fière Denis;
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.
Blood 2002;100(7):2357-66.
2002: Depil Stéphane; Coiteux Valérie; Guillerm Gaëlle; Gyan Emmanuel; Bauters Francis; Fenaux Pierre; Quesnel Bruno
Primary central nervous system lymphoma in immunocompetent adults: poor results mainly associated with high treatment related toxicities.
Leukemia & lymphoma 2002;43(9):1819-22.
2002: Boissel N; Cayuela J M; Preudhomme C; Thomas X; Grardel N; Fund X; Tigaud I; Raffoux E; Rousselot P; Sigaux F; Degos L; Castaigne S; Fenaux P; Dombret H
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1699-704.
2002: Saudemont A; Buffenoir G; Denys A; Desreumaux P; Jouy N; Hetuin D; Bauters F; Fenaux P; Quesnel B
Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1637-44.
2002: Stark Batia; Jeison Marta; Preudhomme Claude; Fenaux Pierre; Ash Shifra; Korek Yifat; Stein Jerry; Zaizov Rina; Yaniv Issac
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins.
British journal of haematology 2002;118(4):1082-6.
2002: Yakoub-Agha I; Fawaz A; Folliot O; Guillerm G; Quesnel B; Fenaux P; Bauters F; Jouet J P; Morschhauser F
Allogeneic bone marrow transplantation in patients with follicular lymphoma: a single center study.
Bone marrow transplantation 2002;30(4):229-34.
2002: Roche-Lestienne Catherine; Soenen-Cornu Valerie; Grardel-Duflos Nathalie; Laï Jean-Luc; Philippe Nathalie; Facon Thierry; Fenaux Pierre; Preudhomme Claude
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.
Blood 2002;100(3):1014-8.
2002: Fenaux Pierre; de Botton Stéphane
[Prognostic factors in myelodysplasia syndromes]
Pathologie-biologie 2002;50(4):256-60.
2002: Leroy Hugues; Roumier Christophe; Grardel-Duflos Nathalie; Macintyre Elizabeth; Lepelley Pascale; Fenaux Pierre; Preudhomme Claude
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
Blood 2002;99(10):3848-50.
2002: Nguyen Stéphanie; Leblanc Thierry; Fenaux Pierre; Witz Francis; Blaise Didier; Pigneux Arnaud; Thomas Xavier; Rigal-Huguet Françoise; Lioure Bruno; Auvrignon Anne; Fière Denis; Reiffers Josy; Castaigne Sylvie; Leverger Guy; Harousseau Jean-Luc; Socié Gérard; Dombret Hervé
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
Blood 2002;99(10):3517-23.
2002: Dombret Hervé; Fenaux Pierre; Soignet Steven L; Tallman Martin S
Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapy.
Seminars in hematology 2002;39(2 Suppl 1):8-13.
2002: Dalle Jean Hughes; Fournier Martine; Nelken Brigitte; Mazingue Françoise; Laï Jean-Luc; Bauters Francis; Fenaux Pierre; Quesnel Bruno
p16(INK4a) immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia.
Blood 2002;99(7):2620-3.
2002: Vereecque Rodolphe; Gonzalez Ricardo; Fenaux Pierre; Quesnel Bruno
Systemic injection of GM-CSF increases survival in a murine model of acute leukemia.
Haematologica 2002;87(2):ELT13.
2002: Grardel N; Roumier C; Soenen V; Lai J L; Plantier I; Gheveart C; Cosson A; Fenaux P; Preudhomme C
Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(1):150-1.
2001: Ribrag V; Bibeau F; El Weshi A; Frayfer J; Fadel C; Cebotaru C; Laribi K; Fenaux P
Primary breast lymphoma: a report of 20 cases.
British journal of haematology 2001;115(2):253-6.
2001: Cassinat B; Chevret S; Zassadowski F; Balitrand N; Guillemot I; Menot M L; Degos L; Fenaux P; Chomienne C;
In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome.
Blood 2001;98(9):2862-4.
2001: Rose C; Cambier N; Mahieu M; Ernst O; Fenaux P
[Iron overload and myelodysplastic syndromes]
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(5):422-32.
2001: Ribrag V; Ell Hajj M; Janot F; Girinsky T; Domenge C; Schwaab G; Fenaux P; Bosq J
Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(7):1123-6.
2001: Soenen V; Lepelley P; Gyan E; Preudhomme C; Lai J L; Bauters F; Fenaux P; Quesnel B
Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(7):1054-9.
2001: Guillerm G; Gyan E; Wolowiec D; Facon T; Avet-Loiseau H; Kuliczkowski K; Bauters F; Fenaux P; Quesnel B
p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance.
Blood 2001;98(1):244-6.
2001: Bourgeois E; Caulier M T; Rose C; Dupriez B; Bauters F; Fenaux P
Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(6):950-3.
2001: Vantelon J M; Munck J N; Bourhis J H; Pico J L; Fadel C; Ulusakarya A; Carde P; Fenaux P; Ribrag V
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy.
Bone marrow transplantation 2001;27(5):531-6.
2001: Nisse C; Haguenoer J M; Grandbastien B; Preudhomme C; Fontaine B; Brillet J M; Lejeune R; Fenaux P
Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.
British journal of haematology 2001;112(4):927-35.
2000: De Botton S; Chevret S; Sanz M; Dombret H; Thomas X; Guerci A; Fey M; Rayon C; Huguet F; Sotto J J; Gardin C; Cony Makhoul P; Travade P; Solary E; Fegueux N; Bordessoule D; San Miguel J; Link H; Desablens B; Stamatoullas A; Deconinck E; Geiser K; Hess U; Maloisel F; Castaigne S; Preudhomme C; Chomienne C; Degos L; Fenaux P;
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
British journal of haematology 2000;111(3):801-6.
2000: Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai J L; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert J P; Cosson A; Fenaux P
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Blood 2000;96(8):2862-9.
2000: Poulain S; Lepelley P; Preudhomme C; Cambier N; Cornillon J; Wattel E; Cosson A; Fenaux P
Expression of the multidrug resistance-associated protein in myelodysplastic syndromes.
British journal of haematology 2000;110(3):591-8.
2000: Hofmann W K; Kell W J; Fenaux P; Castaigne S; Ganser A; Chomienne C; Burnett R; Kowal C; Hoelzer D; Burnett A K
Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(9):1583-8.
2000: Fenaux P; Chevret S; Guerci A; Fegueux N; Dombret H; Thomas X; Sanz M; Link H; Maloisel F; Gardin C; Bordessoule D; Stoppa A M; Sadoun A; Muus P; Wandt H; Mineur P; Whittaker J A; Fey M; Daniel M T; Castaigne S; Degos L
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(8):1371-7.
2000: Vereecque R; Buffenoir G; Preudhomme C; Hetuin D; Bauters F; Fenaux P; Quesnel B
Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.
Gene therapy 2000;7(15):1312-6.
2000: Cambier N; Soenen-Cornu V; Laï J L; Cosson A; Fenaux P; Preudhomme C
Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
Haematologica 2000;85(6):664-5.
2000: Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn J Y; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque J P; Naccache P; Chomienne C; Degos L; Fenaux P
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(6):1006-13.
2000: Preudhomme C; Roumier C; Hildebrand M P; Dallery-Prudhomme E; Lantoine D; Laï J L; Daudignon A; Adenis C; Bauters F; Fenaux P; Kerckaert J P; Galiègue-Zouitina S
Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma.
Oncogene 2000;19(16):2023-32.
2000: Vereecque R; Buffenoir G; Gonzalez R; Cambier N; Hetuin D; Bauters F; Fenaux P; Quesnel B
gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells.
British journal of haematology 2000;108(4):825-31.
2000: Vantelon J M; Koscielny S; Brault P; Bourhis J H; Ribrag V; Pico J; Fenaux P; Munck J N
Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice.
Bone marrow transplantation 2000;25(5):495-9.
2000: Cassinat B; Zassadowski F; Balitrand N; Barbey C; Rain J D; Fenaux P; Degos L; Vidaud M; Chomienne C
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):324-8.
2000: Morschhauser F; Cayuela J M; Martini S; Baruchel A; Rousselot P; Socié G; Berthou P; Jouet J P; Straetmans N; Sigaux F; Fenaux P; Preudhomme C
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):788-94.
2000: Da Silva N; Meyer-Monard S; Menot M L; Parrado A; Lebel A; Balitrand N; Fenaux P; Micléa J M; Rousselot P; Degos L; Dombret H; Chomienne C
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(5):316-28.
2000: Roumier C; Galiègue-Zouitina S; Bastard C; Soenen V; Laï J L; Denis C; Buchonnet G; Kerckaert J P; Cosson A; Fenaux P; Preudhomme C
FISH analysis with a YAC probe improves detection of LAZ3/BCL6 rearrangement in non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):117-25.
2000: Ulusakarya A; Chachaty E; Vantelon J M; Youssef A; Tancrède C; Pico J L; Bourhis J H; Fenaux P; Munck J N
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):111-6.
1999: Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai J L; Cosson A; Fenaux P; Preudhomme C
p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Haematologica 1999;84(12):1075-80.
1999: Archimbaud E; Ottmann O G; Yin J A; Lechner K; Dombret H; Sanz M A; Heil G; Fenaux P; Brugger W; Barge A; O'Brien-Ewen C; Matcham J; Hoelzer D
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia.
Blood 1999;94(11):3694-701.
1999: Gonzalez R; Vereecque R; Wickham T J; Facon T; Hetuin D; Kovesdi I; Bauters F; Fenaux P; Quesnel B
Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells.
Human gene therapy 1999;10(16):2709-17.
1999: Bouabdallah R; Lefrère F; Rose C; Chaïbi P; Harousseau J L; Vernant J P; Castaigne S; Bauduer F; Zini J M; Coso D; Varet B; Robert J; Fenaux P
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(10):1491-6.
1999: Poulain S; Lepelley P; Cambier N; Wattel E; Fenaux P; Cosson A
[Assessment of P glycoprotein expression by immunocytochemistry and flow cytometry coupled with functional efflux analysis: application to acute myeloid leukemia]
Annales de biologie clinique 1999;57(5):595-600.
1999: Thomas X; Fenaux P; Dombret H; Delair S; Dreyfus F; Tilly H; Vekhoff A; Cony-Makhoul P; Leblond V; Troussard X; Cordonnier C; de Revel T; Simon M; Nicolini F; Stoppa A M; Janvier M; Bordessoule D; Rousselot P; Ffrench M; Marie J P; Archimbaud E
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(8):1214-20.
1999: Fenaux P; Chastang C; Chevret S; Sanz M; Dombret H; Archimbaud E; Fey M; Rayon C; Huguet F; Sotto J J; Gardin C; Makhoul P C; Travade P; Solary E; Fegueux N; Bordessoule D; Miguel J S; Link H; Desablens B; Stamatoullas A; Deconinck E; Maloisel F; Castaigne S; Preudhomme C; Degos L
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1999;94(4):1192-200.
1999: Ulusakarya A; Vantelon J M; Munck J N; Fenaux P; Rerat K
Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia.
American journal of hematology 1999;61(2):155-6.
1999: Preudhomme C; Révillion F; Merlat A; Hornez L; Roumier C; Duflos-Grardel N; Jouet J P; Cosson A; Peyrat J P; Fenaux P
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(6):957-64.
1999: Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(5):818-23.
1999: Vereecque R; Buffenoir G; Gonzalez R; Preudhomme C; Fenaux P; Quesnel B
A new murine aggressive leukemic model.
Leukemia research 1999;23(4):415-6.
1999: Wattel E; Solary E; Leleu X; Dreyfus F; Brion A; Jouet J P; Hoang-Ngoc L; Maloisel F; Guerci A; Rochant H; Gratecos N; Casassus P; Janvier M; Brice P; Lepelley P; Fenaux P
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(4):524-9.
1999: Gonzalez R; Vereecque R; Wickham T J; Vanrumbeke M; Kovesdi I; Bauters F; Fenaux P; Quesnel B
Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein.
Gene therapy 1999;6(3):314-20.
1999: Plantier-Colcher I; Dupriez B; Simon M; Detourmignies L; Jouet J P; Fenaux P; Bauters F; Morel P
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(2):282-8.
1999: Merlat A; Lai J L; Sterkers Y; Demory J L; Bauters F; Preudhomme C; Fenaux P
Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(2):250-7.
1999: Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
Advances in experimental medicine and biology 1999;457():57-63.
1999: Wattel E; Solary E; Hecquet B; Caillot D; Ifrah N; Brion A; Milpied N; Janvier M; Guerci A; Rochant H; Cordonnier C; Dreyfus F; Veil A; Hoang-Ngoc L; Stoppa A M; Gratecos N; Sadoun A; Tilly H; Brice P; Lioure B; Desablens B; Pignon B; Abgrall J P; Leporrier M; Fenaux P
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.
Advances in experimental medicine and biology 1999;457():35-46.
1998: De Botton S; Dombret H; Sanz M; Miguel J S; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul D C; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1998;92(8):2712-8.
1998: Wattel E; Solary E; Hecquet B; Caillot D; Ifrah N; Brion A; Mahé B; Milpied N; Janvier M; Guerci A; Rochant H; Cordonnier C; Dreyfus F; Buzyn A; Hoang-Ngoc L; Stoppa A M; Gratecos N; Sadoun A; Stamatoulas A; Tilly H; Brice P; Maloisel F; Lioure B; Desablens B; Fenaux P
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.
British journal of haematology 1998;102(4):1015-24.
1998: Lepelley P; Grardel N; Erny O; Iaru T; Obein V; Cosson A; Fenaux P
Fas/APO-1 (CD95) expression in myelodysplastic syndromes.
Leukemia & lymphoma 1998;30(3-4):307-12.
1998: Laï J L; Daudignon A; Kerckaert J P; Galiègue-Zouitina S; Detourmignies L; Morel P; Bauters F; Fenaux P
Translocation (3;13)(q27;q14): a nonrandom and probably secondary structural change in non-Hodgkin lymphomas.
Cancer genetics and cytogenetics 1998;103(2):140-3.
1998: Lepelley P; Poulain S; Grardel N; Preudhomme C; Cosson A; Fenaux P
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
Leukemia & lymphoma 1998;29(5-6):547-51.
1998: Fenaux P; De Botton S
Retinoic acid syndrome. Recognition, prevention and management.
Drug safety : an international journal of medical toxicology and drug experience 1998;18(4):273-9.
1998: Quesnel B; Guillerm G; Vereecque R; Wattel E; Preudhomme C; Bauters F; Vanrumbeke M; Fenaux P
Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
Blood 1998;91(8):2985-90.
1998: Vallespí T; Imbert M; Mecucci C; Preudhomme C; Fenaux P
Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.
Haematologica 1998;83(3):258-75.
1998: Michallet A S; Lai J L; Bauters F; Fenaux P; Quesnel B
A new case of therapy-related acute myeloid leukaemia with t(8;16)(p11;p13)
British journal of haematology 1998;100(4):801-2.
1998: Soenen V; Preudhomme C; Roumier C; Laï J L; Lepelley P; Facon T; Pagniez D; Fenaux P
Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(2):238-41.
1998: Soenen V; Preudhomme C; Roumier C; Daudignon A; Laï J L; Fenaux P
17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.
Blood 1998;91(3):1008-15.
1998: Preudhomme C; Vanrumbeke M; Detourmignies L; Facon T; Lepelley P; Soussi T; Fenaux P
Very low incidence of p53 antibodies in adult non-Hodgkin's lymphoma and multiple myeloma.
British journal of haematology 1998;100(1):184-6.
1998: Sterkers Y; Preudhomme C; Laï J L; Demory J L; Caulier M T; Wattel E; Bordessoule D; Bauters F; Fenaux P
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
Blood 1998;91(2):616-22.
1997: Hebbar M; Kozlowski D; Wattel E; Mastrini S; Diévart M; Duclos B; Bonaz B; d'Almagne H; Belaiche J; Colombel J F; Fenaux P
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(12):2188-91.
1997: Preudhomme C; Fenaux P
The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies.
British journal of haematology 1997;98(3):502-11.
1997: Wattel E; De Botton S; Luc Laï J; Preudhomme C; Lepelley P; Bauters F; Fenaux P
Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders.
British journal of haematology 1997;98(4):983-91.
1997: Preudhomme C; Nisse C; Hebbar M; Vanrumbeke M; Brizard A; Lai J L; Fenaux P
Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(9):1580-2.
1997: Cambier N; Baruchel A; Schlageter M H; Menot M L; Wattel E; Fenaux P; Chomienne C
Chronic myelomonocytic leukemia: from biology to therapy.
Hematology and cell therapy 1997;39(2):41-8.
1997: Fenaux P; Chomienne C; Degos L
Acute promyelocytic leukemia: biology and treatment.
Seminars in oncology 1997;24(1):92-102.
1997: Preudhomme C; Henic N; Cazin B; Lai J L; Bertheas M F; Vanrumbeke M; Lemoine F; Jouet J P; Deconninck E; Nelken B; Cosson A; Fenaux P
Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(2):294-8.
1996: Lepelley P; Campergue L; Grardel N; Preudhomme C; Cosson A; Fenaux P
Is apoptosis a massive process in myelodysplastic syndromes?
British journal of haematology 1996;95(2):368-71.
1996: Quesnel B; Preudhomme C; Lepelley P; Hetuin D; Vanrumbeke M; Bauters F; Velu T; Fenaux P
Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation.
British journal of haematology 1996;95(2):291-8.
1996: Fenaux P
Myelodysplastic syndromes.
Hematology and cell therapy 1996;38(5):363-80.
1996: Wattel E; Guerci A; Hecquet B; Economopoulos T; Copplestone A; Mahé B; Couteaux M E; Resegotti L; Voglova V; Foussard C; Pegourié B; Michaux J L; Deconinck E; Stoppa A M; Mufti G; Oscier D; Fenaux P
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
Blood 1996;88(7):2480-7.
1996: Chomienne C; Fenaux P; Degos L
Retinoid differentiation therapy in promyelocytic leukemia.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1996;10(9):1025-30.
1996: Hebbar M; Kaplan C; Caulier M T; Wattel E; Morel P; Wetterwald M; Bauters F; Fenaux P
Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
British journal of haematology 1996;94(1):112-5.
1996: Cambier N; Wattel E; Menot M L; Guerci A; Chomienne C; Fenaux P
All-trans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(7):1164-7.
1996: Archimbaud E; Leblond V; Fenaux P; Dombret H; Cordonnier C; Dreyfus F; Cony-Makhoul P; Tilly H; Troussard X; Auzanneau G; Thomas X; Ffrench M; Marie J P
Timed sequential chemotherapy for advanced acute myeloid leukemia.
Hematology and cell therapy 1996;38(2):161-7.
1996: Fenaux P; Degos L
Treatment of acute promyelocytic leukaemia.
Baillière's clinical haematology 1996;9(1):107-28.
1996: Preudhomme C; Philippe N; Macintyre E; Henic N; Lai J L; Jouet J P; Cosson A; Fenaux P
Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: is there a consensus?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(1):186-8.
1996: Henic N; Preudhomme C; Noel M; Lai J; Wetterwald M; Simon M; Fenaux P
Frequency of molecular elimination of Ph1 clone in chronic myelogenous leukemia (CML) with interferon alpha.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(1):185-6.
1996: Wattel E; Vanrumbeke M; Abina M A; Cambier N; Preudhomme C; Haddada H; Fenaux P
Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(1):171-4.
1995: Wattel E; Lepelley P; Merlat A; Sartiaux C; Bauters F; Jouet J P; Fenaux P
Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(11):1870-4.
1995: Agadir A; Cornic M; Lefebvre P; Gourmel B; Jérôme M; Degos L; Fenaux P; Chomienne C
All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2517-23.
1995: Caulier M T; Darloy F; Rose C; Camier G; Morel P; Bauters F; Fenaux P
Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy.
British journal of haematology 1995;91(1):208-11.
1995: Zandecki M; Facon T; Preudhomme C; Vanrumbeke M; Vachee A; Quesnel B; Lai J L; Cosson A; Fenaux P
The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.
Leukemia & lymphoma 1995;18(5-6):497-503.
1995: Morschhauser F; Wattel E; Pagniez D; Lovi V; Rose C; Bauters F; Fenaux P
Glomerular injury in chronic myelomonocytic leukemia.
Leukemia & lymphoma 1995;18(5-6):479-83.
1995: Henic N; Fenaux P; Lai J L; Preudhomme C
RNA for reverse PCR analysis can be obtained from bone marrow cells prepared for cytogenetic analysis and stored at -20 degrees C for several years.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(8):1409-11.
1995: Preudhomme C; Wattel E; Lai J L; Henic N; Meyer L; Noel M P; Cosson A; Jouet J P; Fenaux P
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases.
Leukemia & lymphoma 1995;18(3-4):265-71.
1995: Soenen V; Fenaux P; Flactif M; Lepelley P; Lai J L; Cosson A; Preudhomme C
Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
British journal of haematology 1995;90(3):701-6.
1995: Dombret H; Chastang C; Fenaux P; Reiffers J; Bordessoule D; Bouabdallah R; Mandelli F; Ferrant A; Auzanneau G; Tilly H
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
The New England journal of medicine 1995;332(25):1678-83.
1995: Degos L; Dombret H; Chomienne C; Daniel M T; Micléa J M; Chastang C; Castaigne S; Fenaux P
All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
Blood 1995;85(10):2643-53.
1995: Hebbar M; Brouillard M; Wattel E; Decoulx M; Hatron P Y; Devulder B; Fenaux P
Association of myelodysplastic syndrome and relapsing polychondritis: further evidence.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(4):731-3.
1995: Lepelley P; Soenen V; Preudhomme C; Merlat A; Cosson A; Fenaux P
bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(4):726-30.
1995: Lai J L; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(3):370-81.
1995: Fenaux P; Chastang C; Chomienne C; Castaigne S; Sanz M; Link H; Löwenberg B; Fey M; Archim-Baud E; Degos L
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
Leukemia & lymphoma 1995;16(5-6):431-7.
1995: Archimbaud E; Thomas X; Leblond V; Michallet M; Fenaux P; Cordonnier C; Dreyfus F; Troussard X; Jaubert J; Travade P
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):11-8.
1995: Dombret H; Scrobohaci M L; Daniel M T; Micléa J M; Castaigne S; Chomienne C; Fenaux P; Degos L
In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(1):19-24.
1994: Plantier I; Lai J L; Wattel E; Bauters F; Fenaux P
Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up.
Leukemia research 1994;18(12):885-8.
1994: Flactif M; Laï J L; Fenaux P
Reassessment of an apparent t(12;17)(p11;p11) as an unbalanced t(17;21)(p11;q11) in a case of B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1994;78(1):108-11.
1994: Henic N; Preudhomme C; Vanrumbeke M; Fenaux P
Absence of BCR-ABL rearrangement (with m-bcr breakpoint) in chronic myelomonocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(10):1795-6.
1994: Quesnel B; Preudhomme C; Oscier D; Lepelley P; Collyn-d'Hooghe M; Facon T; Zandecki M; Fenaux P
Over-expression of the MDM2 gene is found in some cases of haematological malignancies.
British journal of haematology 1994;88(2):415-8.
1994: Dubois C; Schlageter M H; de Gentile A; Balitrand N; Toubert M E; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(10):1750-7.
1994: Rose C; Wattel E; Bastion Y; Berger E; Bauters F; Coiffier B; Fenaux P
Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(9):1458-62.
1994: Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(8):1342-9.
1994: Fenaux P; Wattel E; Archimbaud E; Sanz M; Hecquet B; Fegueux N; Guerci A; Link H; Fey M; Castaigne S
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group.
Blood 1994;84(2):666-7.
1994: Archimbaud E; Leblond V; Fenaux P; Dombret H; Cordonnier C; Cony-Makoul P; Dreyfus F; Troussard X; Auzanneau G; Stoppa A M
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91]
Nouvelle revue française d'hématologie 1994;36 Suppl 2():S145-8.
1994: Castaigne S; Archimbaud E; Fenaux P; Bordessoule D; Tilly H; Simon M; Dupriez B; Auzanneau G; Legros M; Tertian G
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90]
Nouvelle revue française d'hématologie 1994;36 Suppl 2():S139-40.
1994: Flactif M; Lai J L; Preudhomme C; Fenaux P
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(6):1012-8.
1994: Dubois C; Schlageter M H; de Gentile A; Guidez F; Balitrand N; Toubert M E; Krawice I; Fenaux P; Castaigne S; Najean Y
Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells.
Blood 1994;83(11):3264-70.
1994: Lepelley P; Soenen V; Preudhomme C; Lai J L; Cosson A; Fenaux P
Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(6):998-1004.
1994: Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai J L; Fenaux P
Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(5):878-80.
1994: Preudhomme C; Vachee A; Morschauser F; Henic N; Cosson A; Fenaux P
Immunoglobulin and T-cell receptor delta gene rearrangements are rarely found in myelodysplastic syndromes in chronic phase.
Leukemia research 1994;18(5):365-71.
1994: Wattel E; Cambier N; Caulier M T; Sautière D; Bauters F; Fenaux P
Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.
British journal of haematology 1994;87(1):205-8.
1994: Preudhomme C; Vachee A; Lepelley P; Vanrumbeke M; Zandecki M; Quesnel B; Cosson A; Fenaux P
Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes.
British journal of haematology 1994;87(1):61-7.
1994: Facon T; Caulier M T; Wattel E; Jouet J P; Bauters F; Fenaux P
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients.
British journal of haematology 1994;86(3):678-80.
1994: Fenaux P
Treatment of newly diagnosed APL. The best choice is not ATRA or chemotherapy ... but a combination of both. European APL Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 2():S59-61; discussion S62.
1994: Fenaux P; Chastang C; Degos L
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 2():S42-7.
1994: Fenaux P
Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 3():S70-2.
1993: Wattel E; Laï J L; Hebbar M; Preudhomme C; Grahek D; Morel P; Bauters F; Fenaux P
De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?
Leukemia research 1993;17(11):921-6.
1993: Preudhomme C; Lepelley P; Vachee A; Soenen V; Quesnel B; Cosson A; Fenaux P
Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(11):1888-90.
1993: Delva L; Cornic M; Balitrand N; Guidez F; Micléa J M; Delmer A; Teillet F; Fenaux P; Castaigne S; Degos L
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
Blood 1993;82(7):2175-81.
1993: Morel P; Hebbar M; Lai J L; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(9):1315-23.
1993: Wattel E; Hecquet B; Grahek D; Hebbar M; Morel P; Lai J L; Bauters F; Fenaux P
Long-term survivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors.
Leukemia research 1993;17(9):733-9.
1993: Preudhomme C; Quesnel B; Vachee A; Lepelley P; Collyn-D'Hooghe M; Wattel E; Fenaux P
Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(8):1291-3.
1993: Facon T; Brouillard M; Duhamel A; Morel P; Simon M; Jouet J P; Bauters F; Fenaux P
Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1553-8.
1993: Preudhomme C; Vachee A; Quesnel B; Wattel E; Cosson A; Fenaux P
Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(7):1071.
1993: Preudhomme C; Fenaux P; Lal J L; Lepelley P; Sartiaux C; Collyn-d'Hooghe M; Zandecki M; Cosson A; Jouet J P; Kerckaert J P
Philadelphia negative, BCR-ABL positive adult acute lymphoblastic leukemia (ALL) in 2 of 39 patients with combined cytogenetic and molecular analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(7):1054-7.
1993: Fenaux P
[Myelodysplastic syndromes or refractory anemias]
La Revue du praticien 1993;43(11):1379-85.
1993: Detourmignies L; Wattel E; Laï J L; Bauters F; Fenaux P
Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases.
Annals of hematology 1993;66(5):235-40.
1993: Archimbaud E; Fenaux P; Reiffers J; Cordonnier C; Leblond V; Travade P; Troussard X; Tilly H; Auzanneau G; Marie J P
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(3):372-7.
1993: Lepelley P; Preudhomme C; Sartiaux C; Ghevaert C; Lai J L; Iaru T; Fenaux P; Cosson A
Immunological detection of myeloperoxidase in poorly differentiated acute leukemia.
European journal of haematology 1993;50(3):155-9.
1993: Facon T; Jouet J P; Lai J L; Fenaux P; Huart J J; Monnier J C; Pagniez D; Bauters F
Early paternity and relapse after bone marrow transplantation.
American journal of hematology 1993;42(2):231-2.
1993: Fenaux P
Management of acute promyelocytic leukemia.
European journal of haematology 1993;50(2):65-73.
1993: Morel P; Dupriez B; Gosselin B; Fenaux P; Estienne M H; Facon T; Jouet J P; Bauters F
Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases.
Cancer 1993;71(1):207-15.
1993: Fenaux P
The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Acta haematologica 1993;89 Suppl 1():22-7.
1992: Preudhomme C; Lai J L; Plantier I; Demory J L; Zandecki M; Fenaux P
Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph).
British journal of haematology 1992;82(3):623-6.
1992: Facon T; Caulier M T; Fenaux P; Plantier I; Marchandise X; Ribet M; Jouet J P; Bauters F
Accessory spleen in recurrent chronic immune thrombocytopenic purpura.
American journal of hematology 1992;41(3):184-9.
1992: Fenaux P; Preudhomme C; Hebbar M
The role of intensive chemotherapy in myelodysplastic syndromes.
Leukemia & lymphoma 1992;8(1-2):43-9.
1992: Auxenfants E; Morel P; Lai J L; Sartiaux C; Detourmignies L; Bauters F; Fenaux P
Secondary acute lymphoblastic leukemia with t (4;11): report on two cases and review of the literature.
Annals of hematology 1992;65(3):143-6.
1992: Morel P; Lepage E; Brice P; Dupriez B; D'Agay M F; Fenaux P; Gosselin B; Bauters F; Gisselbrecht C
Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1078-85.
1992: Fenaux P; Preudhomme C; Laï J L; Quiquandon I; Jonveaux P; Vanrumbeke M; Sartiaux C; Morel P; Loucheux-Lefebvre M H; Bauters F
Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(4):246-50.
1992: Fenaux P; Preudhomme C; Quiquandon I; Jonveaux P; Laï J L; Vanrumbeke M; Loucheux-Lefebvre M H; Bauters F; Berger R; Kerckaert J P
Mutations of the P53 gene in acute myeloid leukaemia.
British journal of haematology 1992;80(2):178-83.
1992: Fenaux P; Jonveaux P; Quiquandon I; Preudhomme C; Lai J L; Vanrumbeke M; Loucheux-Lefebvre M H; Bauters F; Berger R; Kerckaert J P
Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(1):42-6.
1991: Jonveaux P; Fenaux P; Quiquandon I; Pignon J M; Laï J L; Loucheux-Lefebvre M H; Goossens M; Bauters F; Berger R
Mutations in the p53 gene in myelodysplastic syndromes.
Oncogene 1991;6(12):2243-7.
1991: Dighiero G; Travade P; Chevret S; Fenaux P; Chastang C; Binet J L
B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL.
Blood 1991;78(8):1901-14.
1991: Fenaux P; Jonveaux P; Quiquandon I; Laï J L; Pignon J M; Loucheux-Lefebvre M H; Bauters F; Berger R; Kerckaert J P
P53 gene mutations in acute myeloid leukemia with 17p monosomy.
Blood 1991;78(7):1652-7.
1991: Fenaux P; Tertian G; Castaigne S; Tilly H; Leverger G; Guy H; Bordessoule D; Leblay R; Le Gall E; Colombat P
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1556-61.
1991: Facon T; Walter M P; Fenaux P; Morel P; Dupriez B; Gardin C; Jouet J P; Bauters F
Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: a report on 33 patients.
Annals of hematology 1991;63(2):89-93.
1991: Facon T; Zandecki M; Caulier M T; Mannessier L; Fenaux P; Jouet J P; Bauters F
Usefulness of electron microscopy in the diagnosis of congenital dyserythropoietic anemia type I: report of a case.
American journal of hematology 1991;37(4):277-9.
1991: Facon T; Caulier M T; Fenaux P; Wibaut B; Cappelaere A; Quiquandon I; Bauters F
Interferon alpha-2b therapy in refractory adult chronic thrombocytopenic purpura.
British journal of haematology 1991;78(3):464-5.
1991: Dupriez B; Morel P; Fenaux P; Colcher-Plantier I; Facon T; Bauters F
VIM3-ARA C: an effective salvage regimen in refractory or recurrent aggressive non Hodgkin's lymphoma. A report on 18 cases.
Hematological oncology 1991;9(4-5):259-66.
1991: Facon T; Jouet J P; Fenaux P; Walter M P; Lai J L; Jabinet J L; Chambon J P; Bauters F
Isolated pericardial and mediastinal relapse following allogeneic bone marrow transplantation for acute lymphoblastic leukemia.
Transplantation 1991;51(5):1125-6.
1991: Archimbaud E; Leblond V; Michallet M; Cordonnier C; Fenaux P; Travade P; Dreyfus F; Jaubert J; Devaux Y; Fiere D
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia.
Blood 1991;77(9):1894-900.
1991: Fenaux P; Morel P; Rose C; Lai J L; Jouet J P; Bauters F
Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.
British journal of haematology 1991;77(4):497-501.
1991: Jouet J P; Draoui A; Facon T; Noel-Walter M P; Wattre P; Fenaux P; Dupriez B; Morel P; Bauters F
Should all CMV infections after bone marrow transplantation be treated?
Bone marrow transplantation 1991;7 Suppl 2():47.
1990: Chomienne C; Ballerini P; Balitrand N; Huang M E; Krawice I; Castaigne S; Fenaux P; Tiollais P; Dejean A; Degos L
The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(12):802-7.
1990: Chomienne C; Ballerini P; Balitrand N; Daniel M T; Fenaux P; Castaigne S; Degos L
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.
Blood 1990;76(9):1710-7.
1990: Facon T; Mannessier L; Lepelley P; Weill J; Fenaux P; Dupriez B; Morel P; Jouet J P
Congenital diserythropoietic anemia type I. Report on monozygotic twins with associated hemochromatosis and short stature.
Blut 1990;61(4):248-50.
1990: Fenaux P; Simon M; Caulier M T; Lai J L; Goudemand J; Bauters F
Clinical course of essential thrombocythemia in 147 cases.
Cancer 1990;66(3):549-56.
1990: Laï J L; Zandecki M; Fenaux P; Le Baron F; Bauters F; Cosson A; Deminatti M
Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.
Cancer genetics and cytogenetics 1990;46(2):173-83.
1990: Fenaux P; Vanhaesbroucke C; Estienne M H; Preud'homme C; Pagniez D; Facon T; Millot F; Bauters F
Acute monocytic leukaemia in adults: treatment and prognosis in 99 cases.
British journal of haematology 1990;75(1):41-8.
1990: Facon T; Goudemand J; Caron C; Zandecki M; Estienne M H; Fenaux P; Cosson A
Simultaneous occurrence of grey platelet syndrome and idiopathic pulmonary fibrosis: a role for abnormal megakaryocytes in the pathogenesis of pulmonary fibrosis?
British journal of haematology 1990;74(4):542-3.
1990: Fenaux P; Quiquandon I; Caulier M T; Simon M; Walter M P; Bauters F
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 cases.
Blut 1990;60(4):238-41.
1990: Quiquandon I; Fenaux P; Caulier M T; Pagniez D; Huart J J; Bauters F
Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases.
British journal of haematology 1990;74(2):223-8.
1990: Delfau M H; Kerckaert J P; Collyn d'Hooghe M; Fenaux P; Laï J L; Jouet J P; Grandchamp B
Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(1):1-5.
1990: Kerckaert J P; Duterque-Coquillaud M; Collyn-d'Hooghe M; Morel P; Majérus M A; Laï J L; Fenaux P; Bauters F; Debuire B; Loucheux-Lefebvre M H
Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(1):16-9.
1990: Fenaux P; Quiquandon I; Huart J J; Caulier M T; Bauters F
The role of danazol in the treatment of refractory idiopathic thrombocytopenic purpura. A report of 22 cases.
Nouvelle revue française d'hématologie 1990;32(2):143-6.
1990: Estienne M H; Fenaux P; Preudhomme C; Lai J L; Zandecki M; Lepelley P; Cosson A
Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.
Clinical and laboratory haematology 1990;12(1):57-65.
1990: Fenaux P; Preudhomme C; Hélène Estienne M; Morel P; Laï J L; Gardin C; Jouet J P; Bauters F
de novo myelodysplastic syndromes in adults aged 50 or less. A report on 37 cases.
Leukemia research 1990;14(11-12):1053-9.
1990: Collyn d'Hooghe M; Fenaux P; Lantoine D; Loucheux-Lefebvre M; Kerckaert J P
Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases.
Nouvelle revue française d'hématologie 1990;32(3):175-7.
1990: Fenaux P; Collyn d'Hooghe M; Jonveaux P; Lai J L; Bauters F; Loucheux M H; Kerckaert J P
Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia.
Nouvelle revue française d'hématologie 1990;32(5):341-4.
1990: Castaigne S; Chevret S; Lepage E; Guilhot F; Fenaux P; Bordessoule D; Tilly H; Auzanneau G; Tertian G; Guy H
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).
Nouvelle revue française d'hématologie 1990;32(5):297-300.
1989: Lai J L; Deminatti M; Estienne M H; Zandecki M; Nelken B; Fenaux P
A new case of dic(9;12)(p13;p11) in acute lymphocytic leukemia.
Cancer genetics and cytogenetics 1989;42(2):307-8.
1989: Collyn-d'Hooghe M; Fenaux P; Lai J L; Bauters F; Loucheux-Lefebvre M H; Kerckaert J P
Absence of rearrangement of proto-oncogene MET in 88 cases of myelodysplastic syndromes (MDS).
British journal of haematology 1989;73(1):40-2.
1989: Dupriez B; Demory J L; Lai J L; Fenaux P; Bauters F
Prognostic classification of myelofibrosis with myeloid metaplasia.
British journal of haematology 1989;73(1):136-7.
1989: Fenaux P; Estienne M H; Laï J L; Beuscart R; Dupriez B; Jouet J P; Bauters F
[Acquired idiopathic sideroblastic anemia. Apropos of 39 cases]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1989;10(4):323-9.
1989: Fenaux P; Lucidarme D; Laï J L; Bauters F
Favorable cytogenetic abnormalities in secondary leukemia.
Cancer 1989;63(12):2505-8.
1989: Laï J L; Estienne M H; Fenaux P; Lepelley P; Huart J J; Bauters F; Deminatti M
Translocation t(10;17)(p13;q12) in two cases of acute nonlymphocytic leukemia with phagocytic activity of blasts. A new cytogenetic entity?
Cancer genetics and cytogenetics 1989;39(1):45-53.
1989: Fenaux P; Lai J L; Miaux O; Zandecki M; Jouet J P; Bauters F
Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases.
British journal of haematology 1989;71(3):371-6.
1989: Fenaux P; Caulier M T; Hirschauer M C; Beuscart R; Goudemand J; Bauters F
Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases.
European journal of haematology 1989;42(3):259-64.
1989: Laï J L; Fenaux P; Estienne M H; Huart J J; Savary J B; Lepelley P; Jouet J P; Nelken B; Bauters F; Deminatti M
Translocation t(1;19)(q23;p13) in acute lymphoblastic leukemia. A report on six new cases and an unusual t(17;19)(q11;q13), with special reference to prognostic factors.
Cancer genetics and cytogenetics 1989;37(1):9-17.
1989: Lai J L; Fenaux P; Zandecki M; Nelken B; Huart J J; Deminatti M
Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities.
Annales de génétique 1989;32(1):26-32.
1989: Fenaux P; Lemaitre L; Ajana F; Colcher-Plantier I; Jouet J P; Bauters F
Hepatosplenic candidiasis: an overlooked cause of prolonged fever during recovery from an episode of neutropenia.
Nouvelle revue française d'hématologie 1989;31(1):45-9.
1989: Zandecki M; Dupriez B; Fenaux P; Jude B; Watel A; Dracon M; Demory J L; Cosson A
Cytological and ultrastructural assessment of free crystals or precipitates associated with pseudoleukocytosis and pseudothrombocytosis in cryoglobulinemia.
Nouvelle revue française d'hématologie 1989;31(6):397-402.
1988: Fenaux P; Lai J L; Jouet J P; Pollet J P; Bauters F
Aggressive chemotherapy in adult primary myelodysplastic syndromes. A report on 29 cases.
Blut 1988;57(5):297-302.
1988: Demory J L; Dupriez B; Fenaux P; Laï J L; Beuscart R; Jouet J P; Deminatti M; Bauters F
Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases.
Blood 1988;72(3):855-9.
1988: Fenaux P; Beuscart R; Lai J L; Jouet J P; Bauters F
Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1417-24.
1988: Laï J L; Fenaux P; Pollet J P; Estienne M H; Savary J B; Huart J J; Deminatti M
Acute lymphocytic leukemia with 9p anomalies. A report of four additional cases and review of the literature.
Cancer genetics and cytogenetics 1988;33(1):99-109.
1988: Fenaux P; Estienne M H; Lepelley P; Zandecki M; Lai J L; Beuscart R; Jouet J P; Cosson A; Bauters F
Refractory anaemia according to the FAB classification: a report on 69 cases.
European journal of haematology 1988;40(4):318-25.
1988: Fenaux P; Jouet J P; Delerive C; Simon M; Pollet J P; Savinel P; Fabri M C; Ciesla I; Gosselin B; Bauters F
[Hodgkin's disease disclosed by myelofibrosis of primary appearance. Apropos of 2 cases]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1988;9(2):149-52.
1988: Jouet J P; Buchet-Bouverne B; Fenaux P; Pollet J P; Simon M; Walter M P; Leroy J L; Puech F; Delecour M; Bauters F
[Influence of pregnancy on the development of Hodgkin's disease]
Presse médicale (Paris, France : 1983) 1988;17(9):423-7.
1988: Bauters F; Jouet J P; Simon M; Pollet J P; Fenaux P; Walter M P
[Efficacy of pipobroman in the treatment of essential thrombocythemia]
Presse médicale (Paris, France : 1983) 1988;17(2):81.
1987: Laï J L; Fenaux P; Zandecki M; Savary J B; Estienne M H; Jouet J P; Bauters F; Deminatti M
Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9;22) and (15;17).
Cancer genetics and cytogenetics 1987;29(2):311-4.
1987: Simon M; Jouet J P; Fenaux P; Pollet J P; Walter M P; Bauters F
The treatment of adult idiopathic thrombocytopenic purpura. Infusion of vinblastine in ITP.
European journal of haematology 1987;39(3):193-6.
1987: Fenaux P; Jouet J P; Bauters F
[T-cell leukemia and lymphoma]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1987;8(4):407-14.
1987: Lepelley P; Zandecki M; Paquet S; Lerche B; Estienne M H; Fenaux P; Torpier G; Cosson A
Total peroxidase deficiency in eosinophils: a report on twin sisters, one with a refractory anaemia.
European journal of haematology 1987;39(1):77-81.
1987: Fenaux P; Jouet J P; Zandecki M; Lai J L; Simon M; Pollet J P; Bauters F
Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors.
British journal of haematology 1987;65(1):101-6.
1987: Laï J L; Jouet J P; Zandecki M; Savary J B; Fenaux P; Lepelley P; Nelken B; Bauters F; Deminatti M
[(9;11) (p21;q23) translocation: apropos of 2 new cases seen in acute undifferentiated monoblastic AML5a leukemia]
Nouvelle revue française d'hématologie 1987;29(5):303-6.
1987: Fenaux P; Huart J J; Mannessier L; Caulier M T; Zandecki M; Jouet J P; Bauters F
[Ineffective erythropoiesis of immunologic origin with free bilirubin jaundice in an elderly subject]
Nouvelle revue française d'hématologie 1987;29(6):383-6.
1987: Zandecki M; Dupriez B; Laï J L; Fenaux P; Facon T; Lepelley P; Estienne M H; Huart J J; Jouet J P
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases]
Nouvelle revue française d'hématologie 1987;29(6):365-9.
1987: Chomienne C; Najean Y; Degos L; Thomas G; Baumelou E; Calvo F; Casassus P; Ciccone F; Fenaux P; Gris J C
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
Acta haematologica 1987;78 Suppl 1():109-15.
1987: Estienne M H; Lepelley P; Zandecki M; Fenaux P; Jouet J P; Ducoulombier P; Le Baron F; Caron B; Chassaing O; Cosson A
[Cytological diagnosis of myelodysplastic syndromes. Apropos of 200 cases]
Annales de biologie clinique 1987;45(4):402-8.
1986: Walter M P; Jouet J P; Simon M; Pollet J P; Fenaux P; Bauters F
[Dosage and efficacy of antilymphocyte serum in severe bone marrow aplasia]
Presse médicale (Paris, France : 1983) 1986;15(18):846.
1986: Fenaux P; Jouet J P; Zandecki M; Simon M; Pollet J P; Walter M P; Bauters F
[Hemophagocytic syndrome associated with herpes simplex virus. Apropos of a case with a fatal outcome]
Nouvelle revue française d'hématologie 1986;28(5):303-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Pierre Fenaux

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Pierre Fenaux (preview)

All Publications